Pumps present flexibility and precision in managing diabetes, which is a continuous challenge for people affected with diabetes. As per the industry experts, about 400,000 of the 3 Million people residing in the United States with type-I diabetes, make use of insulin pumps, which became commercially prevalent in the 1980s. Such high penetration is also due to the high and increasing disposable income of the US population, which enables them to purchase high priced insulin pumps. Thus, share of the US in global insulin market has been increasing on a continuous basis. The US accounted for a staggering 77.7% share of the global insulin pump market, says our new research report “US Diabetes Market Analysis”.
Further, our report concludes that, the future potential of the US insulin pump market also looks promising. The insulin pump market in the US is anticipated to grow at a CAGR of around 10% during 2011 - 2015. Increasing prevalence of diabetes in the country and market failure of some new techniques, like inhalable insulin will be the main reason for the future growth. Moreover, the US government has taken initiatives to keep a track on the insulin delivery through pumps. The US Food and Drug Administration in 2010 stated an initiative to estimate the safety problems that may arise with external infusion pumps.
Our team of experts has carefully segmented the US diabetes market into insulin delivery devices market and glucose monitoring devices market. Detail segmentation of these markets has also been included in the report. Additionally, the government initiatives and patient profile analysis have been thoroughly described in the report.
Our report “US Diabetes Market Analysis” provides thorough analysis of the various segments of the diabetes market together with the detail study of the investment opportunities. The report has thoroughly examined current market trends; industrial developments, and competitive landscape to enable clients understand the market structure and its progress in coming years. Due consideration has been given to the possible after effects of the recession on the industry. It will help clients to have a proper insight of the current and future outlook of the diabetes market in the US.
For more information visit: http://www.rncos.com/Report/IM299.htm |
